Immune cytolysis of human tumor cells mediated by xenogeneic "immune" RNA: implications for immunotherapy.
D000230:Adenocarcinoma / Q000276:immunology; D000818:Animals; D000937:Antigen-Antibody Reactions; D001943:Breast Neoplasms / Q000276:immunology; D003165:Complement System Proteins; D046508:Culture Techniques; D003601:Cytotoxicity Tests, Immunologic; D003851:Deoxyribonucleases / Q000494:pharmacology; D005260:Female; D005620:Freund's Adjuvant / Q000494:pharmacology; D006168:Guinea Pigs / Q000276:immunology; D006461:Hemolysis; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D007167:Immunotherapy; D007962:Leukocytes / Q000276:immunology; D008221:Lymphoid Tissue / Q000276:immunology; D008545:Melanoma / Q000276:immunology; D009369:Neoplasms / Q000276:immunology* / Q000628:therapy; D011402:Pronase / Q000494:pharmacology; D012313:RNA; D012260:Ribonucleases / Q000494:pharmacology; D012756:Sheep / Q000276:immunology; D013274:Stomach Neoplasms / Q000276:immunology
D012313:RNA; D003165:Complement System Proteins; D005620:Freund's Adjuvant; D003851:Deoxyribonucleases; D012260:Ribonucleases; D011402:Pronase